The Coming Dementia Crisis—and the Cost of Doing Nothing
The Coming Dementia Crisis—and the Cost of Doing Nothing Joel Salinas, founder and chief medical officer of Isaac Health, examines the growing dementia crisis as a looming economic and pol…
DAZN-Pro League row deepens as carriage talks drag on
DAZN-Pro League Dispute Escalates DAZN's negotiations with Belgian TV operators, including Proximus and Telenet, have yet to yield a whole…
TCT 2025: STORM-PE Trial Demonstrates Safety and Efficacy of Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism
TCT 2025: STORM-PE Trial Demonstrates Safety and Efficacy of Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism This new…
Grokipedia launches after brief crash, accused of copying Wikipedia content - Tech Digest
Grokipedia Launch and Controversy Elon Musk's Grokipedia, a rival to Wikipedia, has launched after a brief crash. The website, which conta…
World's Tiniest Pixel Shatters Records... But There's a Catch
World's Tiniest Pixel Shatters Records Scientists have developed the tiniest pixel ever made, measuring 300 × 300 nanometers, and it's bri…
Remedy Robotics partners with Mission Thrombectomy to expand robotic thrombectomy access
Remedy Robotics Partners with Mission Thrombectomy Remedy Robotics has entered a strategic partnership with Mission Thrombectomy, a leadin…
Building the Future, Respecting the Past
Building the Future, Respecting the Past Tbilisi is undergoing a dynamic period of transformation, with sustainable urban development taki…
Cygnet Energy to acquire Kiwetinohk in C$1.4 billion deal | BOE Report
Cygnet Energy to Acquire Kiwetinohk Privately held Cygnet Energy will acquire Kiwetinohk Energy in an all-cash deal valued at C$1.4 billio…
TCT 2025: ShortCUT Trial Compares Cutting Balloon Angioplasty and Intravascular Lithotripsy (IVL) for Calcified Coronary Artery Disease
TCT 2025: ShortCUT Trial Compares Cutting Balloon Angioplasty and Intravascular Lithotripsy (IVL) for Calcified Coronary Artery Disease Th…
SELUTION DeNovo Trial Demonstrates Non-Inferiority of Drug-Eluting Balloon to Standard-of-Care for In-Stent Restenosis: Late-Breaking Results from TCT 2025
SELUTION DeNovo Trial Results The SELUTION DeNovo randomized clinical trial, presented at TCT 2025 in San Francisco, USA, demonstrated non…
Wayfair: Q3 Earnings Snapshot - WTOP News
Wayfair Q3 Earnings Snapshot Wayfair Inc. reported a loss of $99 million in its third quarter, with a loss of 76 cents per share. E…